21 August 2015

1

5 good-to-great biomarker intelligence practices of

innovative diagnostic and life science companies

January 26th, 2016

1011 SW Emkay Drive, Suite 208

Bend, OR 97702

Amplion Inc.

www.amplion.com

21 August 2015

2

HYPE CYCLE

January 2016 http://www.amplion.com

Gartner family of sites, Gartner Hype Cycle, 22nd Jan 2016, http://www.gartner.com/technology/research/methodologies/hype-cycle.jsp

21 August 2015

3

WHY IS INNOVATION IMPORTANT?

Innovation is already being rewarded

Massive opportunity

http://www.amplion.com January 2016

http://www.amplion.com/biomarker-trends/where-are-the-innovative-diagnostics-companies/

21 August 2015

4

10 DIAGNOSTIC INNOVATORS

Annual growth rate in novel biomarkers

30%

January 2016 http://www.amplion.com

http://www.amplion.com/biomarker-trends/10-diagnostics-innovators-smaller-companies-are-leading-the-way

21 August 2015

5

5 good-to-great biomarker intelligence practices

http://www.amplion.com January 2016

21 August 2015

6

Automation

http://www.amplion.com January 2016

21 August 2015

7

Normalization

http://www.amplion.com January 2016

Results must be parsed

Synonyms are not normalized

SEARCH TERM STUDIES RETURNED

ca 125 251

ca-125 251

mucin-16 187

mucin 16 187

MUC16 3

21 August 2015

8

Aggregation

http://www.amplion.com January 2016

Reuse

Expensive 1-off research projects

Identify sales/biz dev opportunities

21 August 2015

9

Analytics

http://www.amplion.com January 2016

Competition

Quick Insights

Trending

21 August 2015

10

Repeatability

http://www.amplion.com January 2016

Deltas

“Watch” areas of interest

Push updates

21 August 2015

11

5 good-to-great biomarker intelligence practices of

innovative diagnostic and life science companies

http://www.amplion.com January 2016

Normalization

Automation

Aggregation

Repeatability

Analytics

21 August 2015

12

Q&A

http://www.amplion.com January 2016